Document is current

Article History

Received: 5 November 2023

Accepted: 15 January 2024

First Online: 12 March 2024

Declarations

:

: Ana Ostojic declares that he has no conflict of interest. Nadim Mahmud declares support from Grifols (investigator-initiated research) K. Rajender Reddy Advisory Board: Mallinckrodt, Spark Therapeutics, Novo Nordisk, Bio Vie. Grant Support ( Paid to the University of Pennsylvania): Mallinckrodt, BMS, Intercept, Bio Vie, Sequana, Grifols, HCC-TARGET, NASH-TARGET, Exact Sciences, Camurus, B and D Device, DSMB: Novartis, Genkyotex, Astra Zeneca.

: Not applicable.

: Not applicable.